Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Mar;26(2):188-194.
doi: 10.1136/tobaccocontrol-2015-052768. Epub 2016 Feb 29.

Randomised controlled trial evaluation of Tweet2Quit: a social network quit-smoking intervention

Affiliations
Randomized Controlled Trial

Randomised controlled trial evaluation of Tweet2Quit: a social network quit-smoking intervention

Cornelia Pechmann et al. Tob Control. 2017 Mar.

Abstract

Background: We evaluated a novel Twitter-delivered intervention for smoking cessation, Tweet2Quit, which sends daily, automated communications to small, private, self-help groups to encourage high-quality, online, peer-to-peer discussions.

Design: A 2-group randomised controlled trial assessed the net benefit of adding a Tweet2Quit support group to a usual care control condition of nicotine patches and a cessation website.

Participants: Participants were 160 smokers (4 cohorts of 40/cohort), aged 18-59 years, who intended to quit smoking, used Facebook daily, texted weekly, and had mobile phones with unlimited texting.

Intervention: All participants received 56 days of nicotine patches, emails with links to the smokefree.gov cessation website, and instructions to set a quit date within 7 days. Additionally, Tweet2Quit participants were enrolled in 20-person, 100-day Twitter groups, and received daily discussion topics via Twitter, and daily engagement feedback via text.

Measures: The primary outcome was sustained abstinence at 7, 30 and 60 days post-quit date.

Results: Participants (mean age 35.7 years, 26.3% male, 31.2% college degree, 88.7% Caucasian) averaged 18.0 (SD=8.2) cigarettes per day and 16.8 (SD=9.8) years of smoking. Participants randomised to Tweet2Quit averaged 58.8 tweets/participant and the average tweeting duration was 47.4 days/participant. Tweet2Quit doubled sustained abstinence out to 60 days follow-up (40.0%, 26/65) versus control (20.0%, 14/70), OR=2.67, CI 1.19 to 5.99, p=0.017. Tweeting via phone predicted tweet volume, and tweet volume predicted sustained abstinence (p<0.001). The daily autocommunications caused tweeting spikes accounting for 24.0% of tweets.

Conclusions: Tweet2Quit was engaging and doubled sustained abstinence. Its low cost and scalability makes it viable as a global cessation treatment.

Trial registration number: NCT01602536.

Keywords: Addiction; Cessation; Denormalization.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JJP is serving as an expert witness in litigation against tobacco companies and has consulted for Pfizer which makes cessation medications.

Figures

Figure 1
Figure 1
Trial profile as a consort flow diagram.

References

    1. Boyd DM, Ellison NB. Social network sites: definition, history, and scholarship. J Comput-Mediat Commun 2007;13:210–30. 10.1111/j.1083-6101.2007.00393.x - DOI
    1. Prochaska JJ, Pechmann C, Kim R, et al. . Twitter=quitter? An analysis of Twitter quit smoking social networks. Tob Control 2012;21:447–9. - PMC - PubMed
    1. Young SD, Cumberland WG, Nianogo R, et al. . The HOPE social media intervention for global HIV prevention in Peru: a cluster randomised controlled trial. Lancet HIV 2015;2:e27–32. - PMC - PubMed
    1. Young SD, Holloway I, Jaganath D, et al. . Project HOPE: online social network changes in an HIV prevention randomized controlled trial for African American and Latino men who have sex with men. Am J Public Health 2014;104:1707–12. 10.2105/AJPH.2014.301992 - DOI - PMC - PubMed
    1. Young SD, Cumberland WG, Lee SJ, et al. . Social networking technologies as an emerging tool for HIV prevention: a cluster randomized trial. Ann Intern Med 2013;159:318–24. 10.7326/0003-4819-159-5-201309030-00005 - DOI - PMC - PubMed

Publication types

Associated data